Niagen Bioscience, Inc.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
NAGE$2.28+10.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit No. | Description | Form | File Number | Exhibit | Filing Date | Filed orFurnishedHerewith |
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant | 10-K | 001-37752 | 3.1 | 3/15/2018 | |
| 3.2 | Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation | 8-K | 001-37752 | 3.1 | 3/19/2025 | |
| 3.3 | Amended and Restated Bylaws of Niagen Bioscience, Inc. | 8-K | 001-37752 | 3.2 | 3/19/2025 | |
| 10.1 | Lease, dated June 12, 2026, by and between DE PARK AVENUE 1100, LLC and ChromaDex, Inc. | X | ||||
| 10.2 | Sales Agreement, dated as of June 26, 2026, by and among the Registrant, Canaccord Genuity LLC and Roth Capital Partners, LLC. | S-3 | 333-297093 | 1.2 | 6/26/2026 | |
| 31.1 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(A) of the Securities Exchange Act of 1934, as amended | X | ||||
| 31.2 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(A) of the Securities Exchange Act of 1934, as amended | X | ||||
| 32.1 | Certification pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002) | X | ||||
| 101.INS | Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||
| 104 | 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.